ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

345 hedge funds and large institutions have $6.15B invested in Intra-Cellular Therapies Inc. in 2024 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 121 increasing their positions, 126 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
345
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$314M
Puts
$96.1M
Net Calls
Net Calls Change

Top Buyers

1 +$65.1M
2 +$46.7M
3 +$23.5M
4
Citadel Advisors
Citadel Advisors
Florida
+$22.4M
5
Ameriprise
Ameriprise
Minnesota
+$21.2M

Top Sellers

1 -$106M
2 -$66.5M
3 -$35.3M
4
DTC
Deep Track Capital
Connecticut
-$34.4M
5
Holocene Advisors
Holocene Advisors
New York
-$24.2M
Name Holding Trade Value Shares
Change
Change in
Stake
251
$253K
252
$246K
253
$246K
254
$245K
255
$245K
256
$238K
257
$236K
258
$234K
259
$232K
260
$229K
261
$228K
262
$223K
263
$220K
264
$220K
265
$220K
266
$205K
267
$203K
268
$202K
269
$201K
270
$186K
271
$184K
272
$183K
273
$171K
274
$151K
275
$150K